Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 1

Review Article

Efficacy of Danshen Class Injection in the Treatment of Acute Cerebral Infarction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Table 1

Results of the network meta-analysis of clinical effectiveness rate (lower left quarter) and neurological impairment (upper right quarter).

A-0.37
(-2.82, 2.04)
-1.16 
(-2.39, 0.07)
-4.38
(-5.07, -3.70)
-4.52
(-5.65, -3.4)
-5.01
(-7.19, -2.84)
-3.45
(-4.96, -1.96)
-2.56
(-5.40, 0.30)
-

1.64
(1.09, 2.55)
B-0.79 
(-3.41, 1.84)
-4.01
(-6.40, -1.60)
-4.15
(-6.70, -1.60)
-4.64
(-7.89, -1.38)
-3.08
(-5.94, -0.22)
-2.19
(-5.92, 1.56)
-

1.40
(1.11, 1.74)
0.89
(0.54, 1.35)
C-3.22
(-4.40, -2.04)
-3.37
(-4.78, -1.93)
-3.86
(-6.4, -1.36)
-2.29
(-4.22, -0.35)
-1.41
(-4.51, 1.70)
-

4.03
(3.41, 4.69)
2.56
(1.65, 3.70)
2.90
(2.31, 3.59)
D-0.14
(-1.38, 1.11)
-0.63
(-2.91, 1.67)
0.93
(-0.70, 2.57)
1.82
(-1.11, 4.74)
-

3.61
(2.80, 4.61)
2.30
(1.40, 3.46)
2.60
(1.95, 3.48)
0.90
(0.69, 1.17)
E-0.49
(-2.96, 1.97)
1.07
(-0.80, 2.96)
1.96
(-1.10, 5.01)
-

4.15
(2.84, 5.87)
2.65
(1.44, 4.31)
3.00
(1.93, 4.43)
1.04
(0.68, 1.53)
1.17
(0.73, 1.81)
F1.56
(-1.07, 4.21)
2.45
(-1.15, 6.04)
-

3.15
(2.35, 4.23)
2.02
(1.12, 3.19)
2.28
(1.55, 3.29)
0.79
(0.56, 1.10)
0.89
(0.58, 1.29)
0.79
(0.48, 1.22)
G0.89
(-2.31, 4.13)
-

5.52
(1.37, 17.00)
3.54
(0.80, 11.3)
4.00 
(0.96, 12.74)
1.38
(0.31, 4.46)
1.56
(0.37, 4.82)
1.38
(0.31, 4.46)
1.79
(0.42, 5.61)
H-

922.30
(2.05, 424.80)
672.30
(1.27, 271.20)
668.30
(1.52, 296.00)
228.10
(0.52, 107.60)
272.00
(0.57, 119.70)
234.10
(0.49, 103.90)
312.20
(0.64, 132.8)
300.80
(0.32, 128.70)
I

A: WM; B: Danshen injection + WM; C: Fufang Danshen injection + WM; D: Danhong injection + WM; E: Danshenchuanxiongqin injection + WM; F: Sodium Tanshinone IIA Sulfonate injection + WM; G: Salvianolate injection + WM; H: Danshen Salvianolic Acids injection + WM; I: Guanxinning injection + WM. The result underlined meant it had statistical significant.